RESUMEN
Gas chromatography-mass spectrometry makes possible the simultaneous measurement of norepinephrine and dopamine in concentrations of 0.1-milligram tissue samples. Specificity of the assay is confirmed both by the retention time of the compound and by the mass to charge ratio of the fragments recorded. The sensitivity is of the order of 0.5 picomole, and linearity of the response is maintained up to at least 200 picomoles.
Asunto(s)
Cromatografía de Gases , Dopamina/análisis , Norepinefrina/análisis , Análisis Espectral , Animales , Núcleo Caudado/análisis , Cerebelo/análisis , Ventrículos Cerebrales/análisis , Ganglios Espinales/análisis , Masculino , Espectrometría de Masas , Metilación , Normetanefrina/análisis , Ratas , Conducto Deferente/análisisRESUMEN
Gas chromatography-mass spectrometry was used to quantitate serotonin, N-acetylserotonin, 5-methoxytryptamine, and melatonin in single rat pineal glands. After gas chromatographic separation, the ion density of specific fragments of each indole was measured with mass spectrometry. Sensitivity of this indole assay is of the order of 10(-12) to 10(-13) mole. Routinely, specificity is based on gas chromatographic retention time and the recording of the ion density generated by specific fragments. Absolute identification of the extracted indoles was based on multiple ion detection.
Asunto(s)
Melatonina/análisis , Glándula Pineal/análisis , Serotonina/análisis , Triptaminas/análisis , Animales , Cromatografía de Gases , Espectrometría de Masas , RatasRESUMEN
In the enzymatic hydroxylation of aromatic amino acids, tetrahydrobiopterin is the essential cofactor. Regeneration of tetrahydrobiopterin requires dihydropteridine reductase, without which there should be a deficiency of hydroxylated amino acids and their products, biogenic amines. Assay of biopsied brain cortex of a patient with a deficiency of dihydropteridine reductases showed low concentrations of serotonin and dopamine, and this was reflected in the concentrations of their major metabolites measured in cerebrospinal fluid from lumbar, ventricular, and subarachnoid spaces. The metabolite concentrations were restored to normal, or above normal, by treatment with specific amino acids which bypass the metabolic block at the hydroxylation step. It is postulated that the seizures and neurological deterioration of the patient were related to a deficiency in the synthesis of biogenic amine neurotransmitters.
Asunto(s)
Aminas Biogénicas/biosíntesis , NADH NADPH Oxidorreductasas/deficiencia , Neurotransmisores/biosíntesis , Fenilcetonurias , 5-Hidroxitriptófano/uso terapéutico , Carbidopa/uso terapéutico , Dopamina/deficiencia , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Lactante , Discapacidad Intelectual/enzimología , Levodopa/uso terapéutico , Masculino , Probenecid/farmacología , Convulsiones/enzimología , Serotonina/deficiencia , Tirosina/uso terapéuticoRESUMEN
The author outlines the pros and cons of data sharing for neuroscientists and argues that continued progress in the field will depend on a cultural shift toward making primary data freely available. He argues in favor of distributed databases to maximize the efficient use of data.
Asunto(s)
Archivos , Bases de Datos Factuales/normas , Neurociencias/normas , Edición/normas , Animales , HumanosRESUMEN
As the amount of basic neuroscientific information increases dramatically, its day-to-day integration and application becomes an increasing difficulty. Technological advances, particularly in computer and information sciences, should allow this information 'explosion' to become more manageable. To this end, the Human Brain Project, an initiative of several NIH Institutes and other United States Government agencies, is being developed to provide a computer database that will allow neuroscientists access to information at all levels of integration, from genes to behavior. In this article Michael Huerta, Stephen Koslow and Alan Leshner outline the genesis and ideas behind the initiative and discuss its future development.
Asunto(s)
Encéfalo/fisiología , Bases de Datos Factuales , Neurología , HumanosRESUMEN
Levels of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in the CSF, and norepinephrine (NE), epinephrine (E), vanillylmandelic acid, normetanephrine, metanephrine, and MHPG in the urine, were measured in 151 hospitalized patients with affective disorders and in 80 healthy controls following a two-week drug-free period. Unipolar and bipolar depressed subjects differed only in NE and E levels. Compared with controls, depressed subjects had higher CSF MHPG levels, women had higher 5-HIAA levels, and men had lower HVA levels. All urinary metabolites were elevated in depression and mania, with the exception of MHPG. The patterns of NE-E differences discriminated among the forms of affective disorders. These data suggest an imbalance of monoamine transmission in depression, characterized by the hyperactive sympathetic nervous system and adrenal medulla. However, MHPG may not be the measure of choice to reflect this imbalance, necessitating measurement of total body monoamine output.
Asunto(s)
Trastornos Psicóticos Afectivos/metabolismo , Aminas Biogénicas/metabolismo , Trastorno Bipolar/metabolismo , Trastorno Depresivo/metabolismo , Adulto , Aminas Biogénicas/líquido cefalorraquídeo , Aminas Biogénicas/orina , Trastorno Bipolar/líquido cefalorraquídeo , Trastorno Bipolar/orina , Trastorno Depresivo/líquido cefalorraquídeo , Trastorno Depresivo/orina , Epinefrina/metabolismo , Femenino , Ácido Homovanílico/metabolismo , Humanos , Ácido Hidroxiindolacético/metabolismo , Masculino , Metoxihidroxifenilglicol/metabolismo , Persona de Mediana Edad , Norepinefrina/metabolismo , Factores SexualesRESUMEN
This is a report on the history and implications of the collaborative effort that evolved from the 1969 National Institute of Mental Health conference on the psychobiology of depression. The major issues identified at that time were the need to (1) assess relative validities of current systems of nosology and (2) retest critical biological hypotheses concerning the etiology and nature of the depressive disorders. Research was required that would be multidisciplinary and involve clinical settings treating diverse types of depression. The objectives and the nature of the biological and clinical collaborative programs that were designed to address these problems are described. These unique programs, initiated in the early 1970s, currently span research on nosology, genetics, neurochemistry, neuroendocrinology, and psychosocial factors. Although these studies are still in the early stages, they have resulted in significant methodologic developments in diagnosis, descriptive psychopathology, and biological measurements.
Asunto(s)
Depresión/sangre , Proyectos de Investigación , Hormona Adrenocorticotrópica/sangre , Conducta , AMP Cíclico/sangre , Depresión/genética , Depresión/psicología , Electrólitos/sangre , Humanos , Hidrocortisona/sangre , Neurotransmisores/sangreRESUMEN
The incidence and severity of somatic symptoms were determined in 132 patients with major depressive disorder and 80 normal controls. The role of somatic symptoms was analyzed in relation to the unipolar-bipolar division, Research Diagnostic Criteria (RDC) subtypes, hypersomnia, and appetite increase. The data suggest that the rate and level of somatic symptoms increased with the severity of depression and age, only appetite loss differentiated unipolar from bipolar patients, and the classic somatic symptoms of depression were present in most RDC subtypes and not exclusively associated with the "endogenous" subtype. Hypersomnia or increased appetite identified two overlapping depressive subgroups; patients in both groups were young and characterized by high interpersonal sensitivity. Hypersomniac depressed patients were less anxious and agitated; patients with increased appetite were more hostile and showed a greater decrease in libido than age-matched and sex-matched patients with neither symptom.
Asunto(s)
Trastorno Depresivo/diagnóstico , Trastornos de Alimentación y de la Ingestión de Alimentos/diagnóstico , Trastornos del Sueño-Vigilia/diagnóstico , Adulto , Factores de Edad , Atención Ambulatoria , Trastorno Bipolar/complicaciones , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/psicología , Trastorno Depresivo/complicaciones , Trastorno Depresivo/psicología , Trastornos de Alimentación y de la Ingestión de Alimentos/complicaciones , Trastornos de Alimentación y de la Ingestión de Alimentos/psicología , Femenino , Hospitalización , Humanos , Masculino , Escalas de Valoración Psiquiátrica , Factores Sexuales , Trastornos del Sueño-Vigilia/complicaciones , Trastornos del Sueño-Vigilia/psicologíaRESUMEN
Treatment of manic patients with lithium carbonate was associated with significant decreases in cerebrospinal fluid (CSF) 3-methoxy-4-hydroxyphenylglycol (MHPG) and urinary norepinephrine excretion. These measures, before treatment, were higher in manic patients than in either depressed or normal subjects and correlated significantly with severity of mania. Levels in CSF of homovanillic acid and 5-hydroxyindoleacetic acid did not correlate with severity or with change during lithium carbonate treatment. Responders (about 70% of the patients) did not differ from nonresponders in pretreatment mania ratings or neurotransmitter measures. The CSF MHPG and urinary norepinephrine excretion were reduced during lithium carbonate treatment in both responders and nonresponders. Unlike the case before treatment, urinary MHPG excretion was higher during treatment in nonresponders than in responders and correlated with several indexes of symptom severity. These results support a relationship between mania and increased noradrenergic function. Treatment outcome, however, was not related exclusively to the reduction of noradrenergic indexes by lithium carbonate since reductions were similar in both responders and nonresponders. Reduced noradrenergic activity may therefore be necessary but not sufficient for successful outcome during lithium carbonate treatment.
Asunto(s)
Trastorno Bipolar/tratamiento farmacológico , Litio/uso terapéutico , Adulto , Anciano , Trastorno Bipolar/metabolismo , Trastorno Bipolar/psicología , Encéfalo/metabolismo , Dopamina/metabolismo , Epinefrina/metabolismo , Femenino , Ácido Homovanílico/metabolismo , Humanos , Ácido Hidroxiindolacético/metabolismo , Litio/farmacología , Carbonato de Litio , Masculino , Metanefrina/metabolismo , Metoxihidroxifenilglicol/metabolismo , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Serotonina/metabolismo , Ácido Vanilmandélico/metabolismoRESUMEN
Pretreatment measures of hypothalamic-pituitary-adrenocortical (HYPAC) function in depressed, manic, and healthy normal subjects showed that nonsuppression on the dexamethasone suppression test (DST) had less positive predictive value for major diagnostic category and was more frequent in normals (8/77) than recently reported, although it was yet more frequent in depressed patients (35/111). Nonsuppression was common in manics (8/16), was similar in unipolar and bipolar depressed patients (35% and 27%, respectively), and did not segregate with melancholic, endogenous, or psychotic depression subtypes. Patterns of post-DST plasma cortisol concentration other than simple escape or nonescape from suppression were common. Nonsuppression of 9 AM plasma cortisol levels on the DST had as good or better diagnostic specificity as nonsuppression of any of three post-DST samples. Nonsuppression was not completely synonymous with HYPAC hypersecretion. Means of pre-DST HYPAC measures (morning plasma cortisol, urine free cortisol, and CSF cortisol levels) were elevated in depressed patients compared with normals. There were significant differences in HYPAC measures of depressed patients studied at different centers. Age correlated positively and body weight negatively with plasma cortisol level.
Asunto(s)
Trastorno Depresivo/diagnóstico , Dexametasona , Hidrocortisona/sangre , Adulto , Factores de Edad , Trastorno Bipolar/sangre , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/fisiopatología , Peso Corporal , Ensayos Clínicos como Asunto , Trastorno Depresivo/sangre , Trastorno Depresivo/fisiopatología , Femenino , Humanos , Hidrocortisona/líquido cefalorraquídeo , Hidrocortisona/orina , Sistema Hipotálamo-Hipofisario/fisiología , Sistema Hipotálamo-Hipofisario/fisiopatología , Masculino , Persona de Mediana Edad , Sistema Hipófiso-Suprarrenal/fisiología , Sistema Hipófiso-Suprarrenal/fisiopatología , Factores SexualesRESUMEN
Depressed patients as a group have been found to excrete greater amounts of catecholamines (CAs) and metabolites than healthy control subjects, but these differences were not uniform for all metabolites. Patients may differ from controls in the metabolism and/or disposition of CAs. We analyzed the suggested metabolic-dispositional differences by determining 24-hour urine values for norepinephrine (NE), epinephrine (E), normetanephrine (NM), metanephrine (M), vanillylmandelic acid (VMA), and 3-methoxy-4-hydroxyphenylglycol (MHPG). For each subject, we calculated ratios of CAs or metabolites to an estimate of CA synthesis and determined ratios of CAs and metabolites to each other based on a precursor-product paradigm. The results indicate that as a group, patients have modestly but significantly greater CA synthesis rates than controls; patients excrete disproportionately more NE and E and disproportionately less MHPG relative to estimated CA synthesis, as well as other metabolites, than do controls; in contrast to NE, E, and MHPG, the increased NM, M, and VMA excretion rates by patients are proportional to each other as well as to the increase in CA synthesis; and the differences in NE, E, and metabolite excretion in the patients as a group are due principally to unipolar rather than bipolar depressives. The differences would be expected if patients, relative to controls, released more NE and E into the circulation. These data indicate the need to measure several CAs and metabolites when evaluating differences between groups since the significance of any given metabolite value needs to be examined in the context of total CA and metabolite production and excretion.
Asunto(s)
Catecolaminas/metabolismo , Trastorno Depresivo/metabolismo , Adulto , Anciano , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/metabolismo , Encéfalo/metabolismo , Trastorno Depresivo/diagnóstico , Diagnóstico Diferencial , Epinefrina/metabolismo , Epinefrina/orina , Femenino , Humanos , Masculino , Metanefrina/metabolismo , Metoxihidroxifenilglicol/metabolismo , Persona de Mediana Edad , Norepinefrina/metabolismo , Norepinefrina/orina , Ácido Vanilmandélico/metabolismoRESUMEN
The National Institute of Mental Health-Clinical Research Branch Collaborative Study investigated 132 drug-free, severely depressed patients and 80 healthy controls. Forty-five percent of the depressed patients excreted markedly elevated levels of urinary epinephrine (E) and metanephrine (MET), while only 5% of healthy controls did so. Using gaussian mixture distributions, we identified two subgroups of depressed patients: one excreting normal levels and the other excreting high levels of urinary E, MET, norepinephrine, and normetanephrine. Cerebrospinal fluid homovanillic acid levels were low in a subgroup of depressed patients. When analyzed by subgroup, the elevated E + MET group had markedly lower cerebrospinal fluid homovanillic acid levels than controls, whereas depressed patients with normal catecholamine levels did not. Since it has been postulated that there are two subgroups of depressed patients, those with low 3-methoxy-4-hydroxyphenylglycol (MHPG) levels and normal 5-hydroxyindoleacetic acid (5-HIAA) levels and those with normal MHPG levels and low 5-HIAA levels, several analyses were performed to see if such a group could be identified. Our analysis failed to find evidence of a subgroup of depressives with low MHPG and normal 5-HIAA levels or normal MHPG and low 5-HIAA levels.
Asunto(s)
Aminas Biogénicas/metabolismo , Trastorno Depresivo/metabolismo , Norepinefrina/metabolismo , Serotonina/metabolismo , Ritmo Circadiano , Trastorno Depresivo/líquido cefalorraquídeo , Trastorno Depresivo/orina , Epinefrina/orina , Femenino , Ácido Homovanílico/líquido cefalorraquídeo , Ácido Homovanílico/orina , Humanos , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Masculino , Metanefrina/orina , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Metoxihidroxifenilglicol/orina , Norepinefrina/orina , Normetanefrina/orinaRESUMEN
In order to determine whether the human pattern of circulating melatonin resembles that previously described in lower animals, men 19-32 years old were exposed to a light-dark cycle with 14 hours of light per day (L:D 14:10). In whites and blacks, nocturnal (dark phase, sleeping) melatonin levels were almost always elevated to 0.05-0.1 ng/ml plasma compared with lower or undetectable levels during the day, measured by the tadpole bioassay. Thin-layer migration of bioactive material was identical to that for melatonin standard. A rhythm with nocturnal elevation of urinary 5-hydroxyindoleacetic acid (5-HIAA) was observed. Nocturnal (sleep phase) rise in blood melatonin (but not urinary 5-HIAA) continued during 21/2 day-night cycle lengths after the onset of constant light. Though the dark phase plasma melatonin rise was less marked after reversal of the sleep-wake cycle (no change in the light cycle), dark phase rise in urinary 5-HIAA continued. Though marked cardiovascular and other effects were produced by intravenous isoproterenol or scopolamine, no definite effect on melatonin levels was observed after either drug during the light phase in waking subjects.
Asunto(s)
Ritmo Circadiano , Ácido Hidroxiindolacético/orina , Melatonina/sangre , Adulto , Oscuridad , Humanos , Isoproterenol/farmacología , Luz , Iluminación , Masculino , Glándula Pineal/fisiología , Escopolamina/farmacología , Sueño , Factores de TiempoRESUMEN
The existence of mixed affective states challenges the idea of specific biological abnormalities in depression and mania. We compared biogenic amines and hypothalamic-pituitary-adrenocortical (HPA) function in mixed manic (n = 8), pure manic (n = 11), agitated bipolar depressed (n = 20), and nonagitated bipolar depressed (n = 27) inpatients (Research Diagnostic Criteria). Mixed manics met Research Diagnostic Criteria for primary manic episodes and also met criteria for major depressive episodes except for duration. The norepinephrine metabolite methoxyhydroxy phenthylene glycol (MHPG) was higher in cerebrospinal fluid from mixed manic than from agitated depressed patients, consistent with differences previously reported between the overall samples of depressed and manic patients. Similarly, patients in a mixed state had higher urinary excretion of norepinephrine (NE) and elevated output of NE relative to its metabolites. HPA activity was similar in mixed manic and agitated depressed patients. These data suggest that mixed manics combine certain biological abnormalities considered to be characteristic of mania and of depression.
Asunto(s)
Aminas Biogénicas/metabolismo , Trastorno Depresivo/fisiopatología , Sistema Hipotálamo-Hipofisario/fisiopatología , Sistema Hipófiso-Suprarrenal/fisiopatología , Agitación Psicomotora/fisiopatología , Adulto , Anciano , Trastorno Depresivo/diagnóstico , Trastorno Depresivo/psicología , Dexametasona , Femenino , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Hidrocortisona/sangre , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Masculino , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Persona de Mediana Edad , Norepinefrina/orina , Agitación Psicomotora/diagnóstico , Agitación Psicomotora/psicologíaRESUMEN
The effects of amitriptyline (AMI) or imipramine (IMI) on levels of 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG), 5-hydroxyindoleacetic acid (5-HIAA), and homovanillic acid (HVA) (the major brain metabolites of the neurotransmitters norepinephrine [NE], serotonin [5-HT], and dopamine [DA]) in cerebrospinal fluid were determined in 66 subjects with unipolar and bipolar depression. There were significant reductions in MHPG and 5-HIAA levels for the depressed group taken as a whole, but levels of HVA did not change significantly. The changes were similar when subjects were grouped as treated with AMI and IMI and with unipolar and bipolar depression. Reductions in MHPG and 5-HIAA levels were greater in women than in men. In all subjects with depression and in those treated with AMI and IMI, amine metabolite changes did not differ significantly between those who had a positive clinical response to drug therapy and those who did not. Responders with bipolar depression had smaller reductions in MHPG levels than did responders with unipolar depression. The similar effects of AMI and IMI on MHPG and 5-HIAA differ from the dissimilar effects of the two drugs on NE and 5-HT amine uptake systems reported in animal and in in vitro studies. Results provide conclusive evidence of the effects of AMI and IMI on noradrenergic and serotonergic (but not dopaminergic) systems in patients with depression.
Asunto(s)
Amitriptilina/uso terapéutico , Trastorno Bipolar/tratamiento farmacológico , Trastorno Depresivo/tratamiento farmacológico , Imipramina/uso terapéutico , Adulto , Trastorno Bipolar/líquido cefalorraquídeo , Trastorno Depresivo/líquido cefalorraquídeo , Dopamina/metabolismo , Método Doble Ciego , Femenino , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Masculino , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Persona de Mediana Edad , Norepinefrina/metabolismo , Serotonina/metabolismo , Factores SexualesRESUMEN
In a study of 19 manic patients, the authors found that eight suffered from mixed mania, a condition in which depressive symptoms are found in the context of classic manic features. The presence of a mixed manic state predicted at least a slower and possibly a poor response to lithium therapy. The authors suggest that the delineation of a subgroup of mixed manic patients might help to identify potential lithium-resistant patients.
Asunto(s)
Trastorno Bipolar/diagnóstico , Adulto , Anciano , Trastorno Bipolar/clasificación , Trastorno Bipolar/tratamiento farmacológico , Trastorno Bipolar/psicología , Trastorno Depresivo/clasificación , Trastorno Depresivo/diagnóstico , Trastorno Depresivo/tratamiento farmacológico , Diagnóstico Diferencial , Femenino , Humanos , Litio/uso terapéutico , Masculino , Persona de Mediana EdadRESUMEN
The activity of the hypothalamic-pituitary-adrenocortical (HPA) axis is often high in depressive illness. The authors studied 132 depressed patients and 80 healthy control subjects. They report a significant direct association between HPA axis activity and adrenomedullary epinephrine secretion in depressed patients. They also found that depressed patients with high HPA activity tend to have lower CSF levels of 5-hydroxyindoleacetic acid, a serotonin metabolite, and modestly lower levels of 3-methoxy-4-hydroxyphenylglycol, a metabolite of epinephrine and norepinephrine, than patients with normal HPA activity. These findings provide potentially important leads for understanding interactions of biogenic amine systems with HPA axis function.
Asunto(s)
Aminas Biogénicas/metabolismo , Trastorno Depresivo/metabolismo , Dexametasona , Hidrocortisona/sangre , Trastorno Depresivo/líquido cefalorraquídeo , Trastorno Depresivo/orina , Epinefrina/metabolismo , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Hidrocortisona/orina , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Masculino , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Norepinefrina/metabolismo , Serotonina/metabolismoRESUMEN
Relationships between pretreatment neurotransmitter metabolite levels and response to imipramine and amitriptyline were studied in 104 depressed patients. Normal values for urinary norepinephrine and low values for urinary MHPG were associated with greater incidence of drug response in bipolar, but not unipolar, patients. For unipolar, but not bipolar, patients low CSF 5-HIAA and high urinary metanephrine values were associated with a greater incidence of drug response. These data indicate that the pretreatment functional state of catecholamine and serotonin systems is associated with type of response to drug treatment. The authors present hypotheses about the association of alterations in serotonin and norepinephrine systems and definable subtypes of depression.
Asunto(s)
Antidepresivos Tricíclicos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Norepinefrina/metabolismo , Serotonina/metabolismo , Amitriptilina/uso terapéutico , Trastorno Bipolar/líquido cefalorraquídeo , Trastorno Bipolar/tratamiento farmacológico , Trastorno Bipolar/orina , Trastorno Depresivo/líquido cefalorraquídeo , Trastorno Depresivo/orina , Femenino , Ácido Homovanílico/líquido cefalorraquídeo , Humanos , Ácido Hidroxiindolacético/líquido cefalorraquídeo , Imipramina/uso terapéutico , Masculino , Metanefrina/orina , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Metoxihidroxifenilglicol/orina , Norepinefrina/orina , Escalas de Valoración PsiquiátricaRESUMEN
This study examined relationships between depressive subtypes, clinical-behavioral characteristics, and hypothalamic-pituitary-adrenocortical (HPA) function in 132 hospitalized depressed patients. There were significant positive correlations between several pre- and postdexamethasone plasma cortisol measures and anxiety, psychomotor disturbance, distressed expression, and sleep disturbance. Few significant relationships were seen between illness severity and HPA function. Virtually no endocrine differences were seen between endogenous and nonendogenous subtypes or between psychotic and nonpsychotic subtypes. These results and the previous literature suggest a profile of depressed patients with HPA overactivation; they are likely to be anxious, to have sleep and psychomotor disturbances, to have lost weight in the current episode, and to be older.